Covid-19 Update

Theresa Villiers Excerpts

Monday 5th October 2020 Commons Chamber

[Matt Hancock]

On the latter point, we take our advice from the Joint Committee on Vaccination and Immunisation, and it will provide the clinical advice. That clinical advice has not been provided yet, because the data has not yet been provided to it in full from the trials that are ongoing. I could not be clearer about that. The Government’s advice on the distribution of the vaccine for clinical purposes comes from the JCVI, and I urge the hon. Gentleman and all others to read its report from 10 days ago. It was an excellent report.

When it comes to the flu vaccine, we have enough to vaccinate every single person who is in a priority group over the age of 65, those who are clinically vulnerable and the children who are eligible for it. We are rolling that out over the forthcoming months. On Sunday, I spoke to the president of the Royal College of GPs, and we discussed the need to make it clear to GPs and pharmacists—they are at the core of the roll-out—and also to the general public that we have enough vaccine. We are rolling it out over the months to come. It is very important that people come forward, and I am really glad they are doing so in record numbers this year, but it does take several weeks to get that done.

[Theresa Villiers (Chipping Barnet) (Con)]

The House should recognise that going from 2,000 tests a day in March to around 250,000 now—hopefully we will see that double over the next few weeks—is a significant achievement, but can the Health Secretary provide any reassurance to sectors such as travel, theatre and events, which are in so much difficulty? Can we use mass testing to help them open up again?

[Matt Hancock]

My right hon. Friend makes a really important and heartfelt plea. I have been working with the travel sector and discussing the matter with them. While the testing capacity is, as it is now, on the current technology, we have to use it for the clinically prioritised groups, but of course we would all love to see when further expansion can mean that we can use testing more broadly in the sorts of ways that she describes.